Nutrients,
Journal Year:
2024,
Volume and Issue:
16(24), P. 4303 - 4303
Published: Dec. 13, 2024
Background:
Coffee
and
tea
are
widely
consumed
beverages,
but
their
long-term
effects
on
cognitive
function
aging
remain
largely
unexplored.
Lifestyle
interventions,
particularly
dietary
habits,
offer
promising
strategies
for
enhancing
performance
preventing
decline.
Methods:
This
study
utilized
data
from
the
UK
Biobank
cohort
(n
=
12,025)
to
examine
associations
between
filtered
coffee,
green
tea,
standard
consumption
neural
network
functional
connectivity
across
seven
resting-state
networks.
We
focused
networks
spanning
prefrontal
occipital
areas
that
linked
complex
behavioral
functions.
Linear
mixed
models
were
used
assess
main
of
coffee
consumption,
as
well
interactions
with
Apolipoprotein
E
(APOE)
genetic
risk—the
strongest
risk
factor
Alzheimer’s
disease
(AD).
Results:
Higher
was
associated
increased
in
several
networks,
including
Motor
Execution,
Sensorimotor,
Fronto-Cingular,
a
Prefrontal
+
‘What’
Pathway
Network.
Similarly,
greater
intake
enhanced
Extrastriate
Visual
Primary
Networks.
In
contrast,
higher
reduced
such
Memory
Consolidation,
“What”
The
APOE4
genotype
family
history
AD
influenced
relationship
Consolidation
Additionally,
modified
association
Sensorimotor
Conclusions:
distinct
patterns
brain
activity
may
provide
insights
into
AD-related
changes.
genotype,
particular,
appears
play
significant
role
modulating
these
relationships.
These
findings
enhance
our
knowledge
how
commonly
beverages
influence
potentially
among
older
adults.
Exploration of neuroscience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 24, 2025
Neurodegenerative
disorders,
including
Alzheimer’s,
Parkinson’s,
Huntington’s,
and
amyotrophic
lateral
sclerosis,
are
among
the
most
significant
health
concerns
worldwide,
characterized
by
neuronal
dysfunction,
oxidative
stress,
neuroinflammation,
protein
misfolding.
Epigallocatechin
gallate,
a
green
tea
polyphenol,
has
been
reported
to
possess
multifaceted
neuroprotective
properties.
It
reduces
stress
through
free
radical
scavenging,
activation
of
antioxidant
enzymes,
stabilization
mitochondrial
function.
also
inhibits
neuroinflammation
modulation
key
signaling
pathways.
suppresses
amyloid-beta
aggregation
in
Alzheimer’s
alpha-synuclein
fibrillation
thus
attenuating
toxic
accumulation.
Its
activity
induction
autophagy
promotion
synaptic
plasticity
supports
survival
However,
low
bioavailability
metabolic
instability
hinder
its
translation
into
clinic.
Strategies
nanoparticle
encapsulation,
structural
modifications,
combination
therapies
being
explored
overcome
these
challenges.
Future
research
could
establish
epigallocatechin
gallate
as
viable
candidate
for
managing
neurodegenerative
disorders.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(7), P. 1203 - 1203
Published: March 29, 2025
Alzheimer's
disease
(AD)
is
a
complex
neurodegenerative
disorder
characterized
by
progressive
cognitive
decline,
memory
loss,
and
behavioral
changes.
It
poses
significant
global
health
challenge.
AD
associated
with
the
accumulation
of
amyloid-β
(Aβ)
plaques
neurofibrillary
tangles
(NFTs)
in
brain,
along
chronic
inflammation,
dysfunctional
neurons,
synapse
loss.
While
prevalence
continues
to
rise,
current
FDA-approved
drugs
offer
only
limited
effectiveness.
Emerging
evidence
suggests
that
obesity,
insulin
resistance
(IR),
type
2
diabetes
mellitus
(T2DM)
are
also
implicated
pathogenesis,
epidemiological
studies
animal
models
confirming
impact
IR
on
Aβ
accumulation,
high-fat
diets
exacerbating
accumulation.
Since
neuroinflammation
activated
involves
nuclear
factor
kappa-light-chain-enhancer
B
cell
(NF-κB)
pathway,
inhibition
NF-κB
NLRP3
inflammasome
activation
potential
therapeutic
strategies
AD.
Bioactive
compounds,
including
polyphenols
(resveratrol,
epigallocatechin-3-gallate,
curcumin,
quercetin),
omega-3
polyunsaturated
fatty
acids,
show
promising
results
clinical
trials
for
reducing
levels,
improving
cognition
modulating
signaling
pathways
This
review
explores
interplay
between
IR,
pathology,
emphasizing
dietary
compounds
their
role
oxidative
stress,
as
viable
prevention
treatment.
By
integrating
findings,
observational
studies,
trials,
this
aims
provide
comprehensive
understating
how
metabolic
dysfunctions
bioactive
influence
progression.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 28, 2025
Developing
treatments
for
age-related
diseases
requires
cost-effective
and
efficient
approaches.
Nutrients
natural
metabolites
offer
safer
alternatives
to
synthetic
drugs.
Aging
increases
the
need
solutions
that
protect
health
repair
cells.
Recent
studies
show
nutrients
products
reduce
oxidative
stress,
regulate
metabolism,
influence
longevity-related
genes.
This
review
focuses
on
vitamins,
minerals,
antioxidants,
improve
healthspan
combat
aging.
It
also
discusses
challenges
such
as
standardization,
clinical
validation,
regulatory
approval.
Finally,
emerging
trends,
personalized
nutrition
advanced
delivery
systems,
highlight
potential
of
these
addressing
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(1), P. 63 - 63
Published: Jan. 2, 2024
The
crucial
physiological
process
of
heme
breakdown
yields
biliverdin
(BV)
and
bilirubin
(BR)
as
byproducts.
BV,
BR,
the
enzymes
involved
in
their
production
(the
“yellow
players—YP”)
are
increasingly
documented
endogenous
modulators
human
health.
Mildly
elevated
serum
concentration
has
been
correlated
with
a
reduced
risk
multiple
chronic
pro-oxidant
pro-inflammatory
diseases,
especially
elderly.
BR
BV
per
se
have
demonstrated
to
protect
against
neurodegenerative
which
oxygenase
(HMOX),
main
enzyme
pigments,
is
almost
always
altered.
HMOX
upregulation
interpreted
tentative
defense
ongoing
pathologic
mechanisms.
With
demonstration
that
cells
possess
YP,
propensity
be
modulated,
broad
spectrum
activity
on
signaling
pathways,
YP
assumed
role
an
adjustable
system
can
promote
health
adults.
Based
that,
there
effort
induce
therapeutic
option,
natural
compounds
attractive
alternative
goal,
possibly
requiring
only
minimal
changes
life
style.
We
review
most
recent
evidence
potential
targeting
context
common
condition
adult
elderly
life.
Frontiers in Bioscience-Landmark,
Journal Year:
2023,
Volume and Issue:
28(12), P. 355 - 355
Published: Dec. 28, 2023
Alzheimer's
disease
is
widely
regarded
as
poorly
treated
due
to
poor
conceptualization.
For
40
years,
pathophysiology
has
focused
on
two
culprits,
amyloid-β
induced
plaques
and
hyperphosphorylated
tau
associated
tangles,
with
no
significant
treatment
advance.
This
confounded
by
data
showing
be
an
endogenous
antimicrobial
that
increased
in
a
wide
array
of
diverse
medical
conditions
heightened
inflammation.
article
reviews
the
wider
bodies
pertaining
pathophysiology,
highlighting
role
suppressed
astrocyte
mitochondrial
function
melatonergic
pathway
core
hub
driving
neuronal
loss
dementia.
It
proposed
over
aging
becomes
dysregulated,
at
least
partly
mediated
systemic
processes
involving
10-fold
decrease
pineal
melatonin
leading
attenuated
capacity
night-time
dampen
residual
daytime
Suppressed
also
attenuates
melatonin's
inhibition
glucocorticoid
receptor
nuclear
translocation,
thereby
changing
not
only
stress/hypothalamus-pituitary-adrenal
(HPA)
axis
consequences
but
cortisol
awakening
response,
which
'primes
body
for
coming
day'.
Gut
microbiome-derived
butyrate
inhibits
well
inducing
pathway.
prevents
autocrine
paracrine
effects
limiting
levels
effects.
production
induction
lactate,
decreasing
metabolism
The
lactate
melatonin,
coupled
suppression
decreases
mitophagy,
major
histocompatibility
complex
(MHC)-1.
MHC-1
initiates
chemoattraction
CD8+
t
cells,
destruction
being
driven
'autoimmune'/'immune-mediated'
processes.
may
therefore
conceptualized
initiated
act
astrocytes
hub,
leaving
neurons
deplete
appropriate
metabolic
substrates
co-ordinated
antioxidants.
culminates
'immune-mediated'
cell
death.
Future
research
treatment/prevention
implications
are
indicated.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(13), P. e33496 - e33496
Published: June 26, 2024
Alzheimer's
disease
(AD)
is
the
most
known
neurodegenerative
disease,
and
its
prevalence
predicted
to
increase
significantly.
Discovering
novel
drugs
treatments
for
AD
urgently
needed.
Drugs
from
natural
products
have
been
preferred
lately
due
their
high
potential
low
toxicity.
Citrus
hystrix
DC.
(kaffir
lime;
KL)
one
such
herbal
plant
that
found
abundantly
in
Southeast
Asia
with
many
biological
activities.
In
this
study,
of
bioactive
compounds
KL
peel,
leaf,
essential
oil
as
anti-AD
agents
was
explored
using
network
pharmacology.
First,
were
identified
KNApSAcK
database
related
literature.
Subsequently,
targets
each
corresponding
compound
determined
SEA
Search
Server
Swiss
Target
Prediction
proteins
associated
OMIM,
GenCLiP3,
DisGeNET.
Furthermore,
a
protein–protein
interaction
compound–target
constructed
identify
crucial
by
employing
Cytoscape
v3.9.1.
The
study
continued
pathway
enrichment
analysis
STRING
v1.7.1,
molecular
docking
PyRx
SwissDock,
dynamics
simulation
YASARA
further
confirmation.
Our
results
showed
almost
all
secondary
metabolites
targeted
AD-associated
genes,
oxypeucedanin
citrusoside
A
showing
highest
targeting
EGFR
MAPK14,
respectively.
These
inflammatory
oxidative
stress
pathways,
indicating
mechanism
attenuating
clinical
manifestation.
ACS Omega,
Journal Year:
2024,
Volume and Issue:
9(33), P. 35463 - 35474
Published: Aug. 7, 2024
Epigallocatechin-3-gallate
(EGCG)
and
ascorbic
acid
(AA)-loaded
transferosomes
(TRANS)
were
developed
for
brain
delivery.
The
investigation
covered
EGCG-TRANS,
AA-TRANS,
EGCG-AA-TRANS
formulations
using
the
film
hydration
technique.
We
analyzed
formed
to
confirm
presence
of
vesicles
loaded
with
respective
drugs
their
performance
within
a
living
organism.
sizes
particles
measured
correspondingly
at
174.2
±
1.80,
132.7
12.22,
184.31
9.5
nm.
appearance
diffused
rings
in
scanning
electron
microscopic
image
suggests
that
payload
has
crystalline
structure.
atomic
force
microscope
displayed
minimal
surface
irregularities,
potentially
indicating
lipid
layer
on
surface.
Hemolysis
results
indicated
safety
vesicles.
showed
10.23,
7.21,
8.20%
hemolysis
EGCG-AA-TRANS,
respectively.
In
case
release
EGCG
was
determined
be
61.65%
4.61
after
72
h
when
exposed
phosphate
buffer
saline
(pH
7.4).
vivo
studies
show
good
response
against
Alzheimer's
disease
(AD).
(82.166%)
exhibited
higher
percentage
AChE
inhibition
comparison
EGCG-TRANS
(66.550%)
AA-TRANS
(53.466%).
Intranasal
delivery
resulted
approximately
5-fold
enhancement
memory.
Formulation
allowed
AA
accumulate
various
organs,
including
brain.
suggest
could
safe
effective
treating
AD.